Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1996 Apr;5(2):79–94. doi: 10.1155/S0962935196000142

Nasal hyperreactivity and inflammation in allergic rhinitis

I M Garrelds 1,2,✉, C de Graaf-in't Veld 2, R Gerth van Wijk 2, F J Zijlstra 1
PMCID: PMC2365776  PMID: 18475703

Abstract

The history of allergic disease goes back to 1819, when Bostock described his own ‘periodical affection of the eyes and chest’, which he called ‘summer catarrh’. Since they thought it was produced by the effluvium of new hay, this condition was also called hay fever. Later, in 1873, Blackley established that pollen played an important role in the causation of hay fever. Nowadays, the definition of allergy is ‘An untoward physiologic event mediated by a variety of different immunologic reactions’. In this review, the term allergy will be restricted to the IgE-dependent reactions. The most important clinical manifestations of IgE-dependent reactions are allergic conjunctivitis, allergic rhinitis, allergic asthma and atopic dermatitis. However, this review will be restricted to allergic rhinitis. The histopathological features of allergic inflammation involve an increase in blood flow and vascular permeability, leading to plasma exudation and the formation of oedema. In addition, a cascade of events occurs which involves a variety of inflammatory cells. These inflammatory cells migrate under the influence of chemotactic agents to the site of injury and induce the process of repair. Several types of inflammatory cells have been implicated in the pathogenesis of allergic rhinitis. After specific or nonspecific stimuli, inflammatory mediators are generated from cells normally found in the nose, such as mast cells, antigen-presenting cells and epithelial cells (primary effector cells) and from cells recruited into the nose, such as basophils, eosinophils, lymphocytes, platelets and neutrophils (secondary effector cells). This review describes the identification of each of the inflammatory cells and their mediators which play a role in the perennial allergic processes in the nose of rhinitis patients.

Full Text

The Full Text of this article is available as a PDF (2.0 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al-Bazzaz F. J., Kelsey J. G., Kaage W. D. Substance P stimulation of chloride secretion by canine tracheal mucosa. Am Rev Respir Dis. 1985 Jan;131(1):86–89. doi: 10.1164/arrd.1985.131.1.86. [DOI] [PubMed] [Google Scholar]
  2. Alam R., Sim T. C., Hilsmeier K., Grant J. A. Development of a new technique for recovery of cytokines from inflammatory sites in situ. J Immunol Methods. 1992 Oct 19;155(1):25–29. doi: 10.1016/0022-1759(92)90267-w. [DOI] [PubMed] [Google Scholar]
  3. Albegger K. Aktuelle pathophysiologische Aspekte der allergischen Rhinitis. Teil I. HNO. 1990 Sep;38(9):305–308. [PubMed] [Google Scholar]
  4. Asano K., Chee C. B., Gaston B., Lilly C. M., Gerard C., Drazen J. M., Stamler J. S. Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):10089–10093. doi: 10.1073/pnas.91.21.10089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bacci S., Arbi-Riccardi R., Mayer B., Rumio C., Borghi-Cirri M. B. Localization of nitric oxide synthase immunoreactivity in mast cells of human nasal mucosa. Histochemistry. 1994 Aug;102(2):89–92. doi: 10.1007/BF00269011. [DOI] [PubMed] [Google Scholar]
  6. Barnes P. J. Asthma as an axon reflex. Lancet. 1986 Feb 1;1(8475):242–245. doi: 10.1016/s0140-6736(86)90777-4. [DOI] [PubMed] [Google Scholar]
  7. Barnes P. J. Neural mechanisms in asthma. Br Med Bull. 1992 Jan;48(1):149–168. doi: 10.1093/oxfordjournals.bmb.a072531. [DOI] [PubMed] [Google Scholar]
  8. Bascom R., Pipkorn U., Lichtenstein L. M., Naclerio R. M. The influx of inflammatory cells into nasal washings during the late response to antigen challenge. Effect of systemic steroid pretreatment. Am Rev Respir Dis. 1988 Aug;138(2):406–412. doi: 10.1164/ajrccm/138.2.406. [DOI] [PubMed] [Google Scholar]
  9. Bascom R., Wachs M., Naclerio R. M., Pipkorn U., Galli S. J., Lichtenstein L. M. Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment. J Allergy Clin Immunol. 1988 Mar;81(3):580–589. [PubMed] [Google Scholar]
  10. Beasley R., Roche W. R., Roberts J. A., Holgate S. T. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis. 1989 Mar;139(3):806–817. doi: 10.1164/ajrccm/139.3.806. [DOI] [PubMed] [Google Scholar]
  11. Becker C. G., Nachman R. L. Contractile proteins of endothelial cells, platelets and smooth muscle. Am J Pathol. 1973 Apr;71(1):1–22. [PMC free article] [PubMed] [Google Scholar]
  12. Bischoff S. C., Brunner T., De Weck A. L., Dahinden C. A. Interleukin 5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists. J Exp Med. 1990 Dec 1;172(6):1577–1582. doi: 10.1084/jem.172.6.1577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Bischoff S. C., de Weck A. L., Dahinden C. A. Interleukin 3 and granulocyte/macrophage-colony-stimulating factor render human basophils responsive to low concentrations of complement component C3a. Proc Natl Acad Sci U S A. 1990 Sep;87(17):6813–6817. doi: 10.1073/pnas.87.17.6813. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Black J. L., Armour C. L., Vincenc K. S., Johnson P. R. A comparison of the contractile activity of PGD2 and PGF2 alpha on human isolated bronchus. Prostaglandins. 1986 Jul;32(1):25–31. doi: 10.1016/0090-6980(86)90139-5. [DOI] [PubMed] [Google Scholar]
  15. Black J. W., Duncan W. A., Durant C. J., Ganellin C. R., Parsons E. M. Definition and antagonism of histamine H 2 -receptors. Nature. 1972 Apr 21;236(5347):385–390. doi: 10.1038/236385a0. [DOI] [PubMed] [Google Scholar]
  16. Borres M. P., Irander K., Björkstén B. Metachromatic cells in nasal mucosa after allergen challenge. Allergy. 1990 Feb;45(2):98–103. doi: 10.1111/j.1398-9995.1990.tb00465.x. [DOI] [PubMed] [Google Scholar]
  17. Borson D. B., Corrales R., Varsano S., Gold M., Viro N., Caughey G., Ramachandran J., Nadel J. A. Enkephalinase inhibitors potentiate substance P-induced secretion of 35SO4-macromolecules from ferret trachea. Exp Lung Res. 1987;12(1):21–36. doi: 10.3109/01902148709068812. [DOI] [PubMed] [Google Scholar]
  18. Borum P., Grønborg H., Brofeldt S., Mygind N. Nasal reactivity in rhinitis. Eur J Respir Dis Suppl. 1983;128(Pt 1):65–71. [PubMed] [Google Scholar]
  19. Bradding P., Roberts J. A., Britten K. M., Montefort S., Djukanovic R., Mueller R., Heusser C. H., Howarth P. H., Holgate S. T. Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol. 1994 May;10(5):471–480. doi: 10.1165/ajrcmb.10.5.8179909. [DOI] [PubMed] [Google Scholar]
  20. Braquet P., Touqui L., Shen T. Y., Vargaftig B. B. Perspectives in platelet-activating factor research. Pharmacol Rev. 1987 Jun;39(2):97–145. [PubMed] [Google Scholar]
  21. Broide D. H., Lotz M., Cuomo A. J., Coburn D. A., Federman E. C., Wasserman S. I. Cytokines in symptomatic asthma airways. J Allergy Clin Immunol. 1992 May;89(5):958–967. doi: 10.1016/0091-6749(92)90218-q. [DOI] [PubMed] [Google Scholar]
  22. Bruynzeel P. L., Koenderman L., Kok P. T., Hameling M. L., Verhagen J. Platelet-activating factor (PAF-acether) induced leukotriene C4 formation and luminol dependent chemiluminescence by human eosinophils. Pharmacol Res Commun. 1986 Aug;18 (Suppl):61–69. doi: 10.1016/0031-6989(86)90039-1. [DOI] [PubMed] [Google Scholar]
  23. Buckle F. G., Cohen A. B. Nasal mucosal hyperpermeability to macromolecules in atopic rhinitis and extrinsic asthma. J Allergy Clin Immunol. 1975 Apr;55(4):213–221. doi: 10.1016/0091-6749(75)90139-6. [DOI] [PubMed] [Google Scholar]
  24. Cassatella M. A., Bazzoni F., Ceska M., Ferro I., Baggiolini M., Berton G. IL-8 production by human polymorphonuclear leukocytes. The chemoattractant formyl-methionyl-leucyl-phenylalanine induces the gene expression and release of IL-8 through a pertussis toxin-sensitive pathway. J Immunol. 1992 May 15;148(10):3216–3220. [PubMed] [Google Scholar]
  25. Castells M. C., Irani A. M., Schwartz L. B. Evaluation of human peripheral blood leukocytes for mast cell tryptase. J Immunol. 1987 Apr 1;138(7):2184–2189. [PubMed] [Google Scholar]
  26. Chavance M., Herbeth B., Kauffmann F. Seasonal patterns of circulating basophils. Int Arch Allergy Appl Immunol. 1988;86(4):462–464. doi: 10.1159/000234636. [DOI] [PubMed] [Google Scholar]
  27. Churchill L., Friedman B., Schleimer R. P., Proud D. Production of granulocyte-macrophage colony-stimulating factor by cultured human tracheal epithelial cells. Immunology. 1992 Jan;75(1):189–195. [PMC free article] [PubMed] [Google Scholar]
  28. Clark R. A., Gallin J. I., Kaplan A. P. The selective eosinophil chemotactic activity of histamine. J Exp Med. 1975 Dec 1;142(6):1462–1476. doi: 10.1084/jem.142.6.1462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Clement P. A. Committee report on standardization of rhinomanometry. Rhinology. 1984 Sep;22(3):151–155. [PubMed] [Google Scholar]
  30. Cockcroft D. W., Ruffin R. E., Dolovich J., Hargreave F. E. Allergen-induced increase in non-allergic bronchial reactivity. Clin Allergy. 1977 Nov;7(6):503–513. doi: 10.1111/j.1365-2222.1977.tb01481.x. [DOI] [PubMed] [Google Scholar]
  31. Coleridge H. M., Coleridge J. C., Ginzel K. H., Baker D. G., Banzett R. B., Morrison M. A. Stimulation of 'irritant' receptors and afferent C-fibres in the lungs by prostaglandins. Nature. 1976 Dec 2;264(5585):451–453. doi: 10.1038/264451a0. [DOI] [PubMed] [Google Scholar]
  32. Columbo M., Casolaro V., Warner J. A., MacGlashan D. W., Jr, Kagey-Sobotka A., Lichtenstein L. M. The mechanism of mediator release from human basophils induced by platelet-activating factor. J Immunol. 1990 Dec 1;145(11):3855–3861. [PubMed] [Google Scholar]
  33. Connell J. T. Quantitative intranasal pollen challenges. 3. The priming effect in allergic rhinitis. J Allergy. 1969 Jan;43(1):33–44. doi: 10.1016/0021-8707(69)90018-5. [DOI] [PubMed] [Google Scholar]
  34. Copas J. L., Borgeat P., Gardiner P. J. The actions of 5-, 12-, and 15-HETE on tracheobronchial smooth muscle. Prostaglandins Leukot Med. 1982 Feb;8(2):105–114. doi: 10.1016/s0262-1746(82)80002-4. [DOI] [PubMed] [Google Scholar]
  35. Corrado O. J., Gould C. A., Kassab J. Y., Davies R. J. Nasal response of rhinitic and non-rhinitic subjects to histamine and methacholine: a comparative study. Thorax. 1986 Nov;41(11):863–868. doi: 10.1136/thx.41.11.863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Corrigan C. J., Haczku A., Gemou-Engesaeth V., Doi S., Kikuchi Y., Takatsu K., Durham S. R., Kay A. B. CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5. Effect of glucocorticoid therapy. Am Rev Respir Dis. 1993 Mar;147(3):540–547. doi: 10.1164/ajrccm/147.3.540. [DOI] [PubMed] [Google Scholar]
  37. Costa J. J., Matossian K., Resnick M. B., Beil W. J., Wong D. T., Gordon J. R., Dvorak A. M., Weller P. F., Galli S. J. Human eosinophils can express the cytokines tumor necrosis factor-alpha and macrophage inflammatory protein-1 alpha. J Clin Invest. 1993 Jun;91(6):2673–2684. doi: 10.1172/JCI116506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Cox G., Ohtoshi T., Vancheri C., Denburg J. A., Dolovich J., Gauldie J., Jordana M. Promotion of eosinophil survival by human bronchial epithelial cells and its modulation by steroids. Am J Respir Cell Mol Biol. 1991 Jun;4(6):525–531. doi: 10.1165/ajrcmb/4.6.525. [DOI] [PubMed] [Google Scholar]
  39. Curry J. J. THE ACTION OF HISTAMINE ON THE RESPIRATORY TRACT IN NORMAL AND ASTHMATIC SUBJECTS. J Clin Invest. 1946 Nov;25(6):785–791. doi: 10.1172/JCI101764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Cuss F. M., Dixon C. M., Barnes P. J. Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man. Lancet. 1986 Jul 26;2(8500):189–192. doi: 10.1016/s0140-6736(86)92489-x. [DOI] [PubMed] [Google Scholar]
  41. Dale H. H., Laidlaw P. P. The physiological action of beta-iminazolylethylamine. J Physiol. 1910 Dec 31;41(5):318–344. doi: 10.1113/jphysiol.1910.sp001406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Desreumaux P., Janin A., Colombel J. F., Prin L., Plumas J., Emilie D., Torpier G., Capron A., Capron M. Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease. J Exp Med. 1992 Jan 1;175(1):293–296. doi: 10.1084/jem.175.1.293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Fallah H. A., Maillard J. L., Voisin G. A. Regulatory mast cells. I Suppressive action of their products on an in vitro primary immune reaction. Ann Immunol (Paris) 1975 Oct-Dec;126(5-6):669–682. [PubMed] [Google Scholar]
  44. Feinmark S. J., Lindgren J. A., Claesson H. E., Malmsten C., Samuelsson B. Stimulation of human leukocyte degranulation by leukotriene B4 and its omega-oxidized metabolites. FEBS Lett. 1981 Dec 21;136(1):141–144. doi: 10.1016/0014-5793(81)81233-1. [DOI] [PubMed] [Google Scholar]
  45. Ferguson H., Davies R. J. Late phase nasal reactions--reviewed and revisited. Respir Med. 1991 May;85(3):247–249. doi: 10.1016/s0954-6111(06)80089-2. [DOI] [PubMed] [Google Scholar]
  46. Finazzi-Agrò A., Menichelli A., Persiani M., Biancini G., Del Principe D. Hydrogen peroxide release from human blood platelets. Biochim Biophys Acta. 1982 Sep 17;718(1):21–25. doi: 10.1016/0304-4165(82)90004-6. [DOI] [PubMed] [Google Scholar]
  47. Fisher E. W., Lund V. J., Scadding G. K. Acoustic rhinometry in rhinological practice: discussion paper. J R Soc Med. 1994 Jul;87(7):411–413. doi: 10.1177/014107689408700713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Fokkens W. J., Godthelp T., Holm A. F., Blom H., Mulder P. G., Vroom T. M., Rijntjes E. Dynamics of mast cells in the nasal mucosa of patients with allergic rhinitis and non-allergic controls: a biopsy study. Clin Exp Allergy. 1992 Jul;22(7):701–710. doi: 10.1111/j.1365-2222.1992.tb00194.x. [DOI] [PubMed] [Google Scholar]
  49. Foreman J., Jordan C. Histamine release and vascular changes induced by neuropeptides. Agents Actions. 1983 Apr;13(2-3):105–116. doi: 10.1007/BF01967311. [DOI] [PubMed] [Google Scholar]
  50. Freeland H. S., Schleimer R. P., Schulman E. S., Lichtenstein L. M., Peters S. P. Generation of leukotriene B4 by human lung fragments and purified human lung mast cells. Am Rev Respir Dis. 1988 Aug;138(2):389–394. doi: 10.1164/ajrccm/138.2.389. [DOI] [PubMed] [Google Scholar]
  51. Fujisawa T., Abu-Ghazaleh R., Kita H., Sanderson C. J., Gleich G. J. Regulatory effect of cytokines on eosinophil degranulation. J Immunol. 1990 Jan 15;144(2):642–646. [PubMed] [Google Scholar]
  52. Galli S. J. New concepts about the mast cell. N Engl J Med. 1993 Jan 28;328(4):257–265. doi: 10.1056/NEJM199301283280408. [DOI] [PubMed] [Google Scholar]
  53. Garrelds I. M., de Graaf-In 't Veld T., Jansen A. P., van Wijk R. G., Zijlstra F. J. Effect of Fluticasone propionate Aqueous Nasal Spray Treatment on Platelet Activating Factor and Eicosanoid Production By nasal Mucosa in Patients with A house Dust Mite Allergy. Mediators Inflamm. 1994;3(5):381–385. doi: 10.1155/S0962935194000530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Garrelds I. M., van Amsterdam J. G., de Graaf-in't Veld C., Gerth van Wijk R., Zijlstra F. J. Nitric oxide metabolites in nasal lavage fluid of patients with house dust mite allergy. Thorax. 1995 Mar;50(3):275–279. doi: 10.1136/thx.50.3.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Gerth Van Wijk R., Dieges P. H. Comparison of nasal responsiveness to histamine, methacholine and phentolamine in allergic rhinitis patients and controls. Clin Allergy. 1987 Nov;17(6):563–570. doi: 10.1111/j.1365-2222.1987.tb02052.x. [DOI] [PubMed] [Google Scholar]
  56. Gleich G. J., Adolphson C. R. The eosinophilic leukocyte: structure and function. Adv Immunol. 1986;39:177–253. doi: 10.1016/s0065-2776(08)60351-x. [DOI] [PubMed] [Google Scholar]
  57. Gleich G. J., Flavahan N. A., Fujisawa T., Vanhoutte P. M. The eosinophil as a mediator of damage to respiratory epithelium: a model for bronchial hyperreactivity. J Allergy Clin Immunol. 1988 May;81(5 Pt 1):776–781. doi: 10.1016/0091-6749(88)90931-1. [DOI] [PubMed] [Google Scholar]
  58. Goetzl E. J., Pickett W. C. The human PMN leukocyte chemotactic activity of complex hydroxy-eicosatetraenoic acids (HETEs). J Immunol. 1980 Oct;125(4):1789–1791. [PubMed] [Google Scholar]
  59. Golden J. A., Nadel J. A., Boushey H. A. Bronchial hyperirritability in healthy subjects after exposure to ozone. Am Rev Respir Dis. 1978 Aug;118(2):287–294. doi: 10.1164/arrd.1978.118.2.287. [DOI] [PubMed] [Google Scholar]
  60. Goldstein I. M., Malmsten C. L., Kindahl H., Kaplan H. B., Rådmark O., Samuelsson B., Weissmann G. Thromboxane generation by human peripheral blood polymorphonuclear leukocytes. J Exp Med. 1978 Sep 1;148(3):787–792. doi: 10.1084/jem.148.3.787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Gonzalez M. C., Diaz P., Galleguillos F. R., Ancic P., Cromwell O., Kay A. B. Allergen-induced recruitment of bronchoalveolar helper (OKT4) and suppressor (OKT8) T-cells in asthma. Relative increases in OKT8 cells in single early responders compared with those in late-phase responders. Am Rev Respir Dis. 1987 Sep;136(3):600–604. doi: 10.1164/ajrccm/136.3.600. [DOI] [PubMed] [Google Scholar]
  62. Gourdin M. F., Vasconcelos A. W., Tabilio A., Divine M., Farcet J. P., Reyes F. Human mononuclear phagocyte differentiation: a study of the U-937 cell line by ultrastructural cytochemistry and surface antigen analysis. Br J Haematol. 1985 Oct;61(2):281–291. doi: 10.1111/j.1365-2141.1985.tb02827.x. [DOI] [PubMed] [Google Scholar]
  63. Graham D., Henderson F., House D. Neutrophil influx measured in nasal lavages of humans exposed to ozone. Arch Environ Health. 1988 May-Jun;43(3):228–233. doi: 10.1080/00039896.1988.9934938. [DOI] [PubMed] [Google Scholar]
  64. Greiff L., Pipkorn U., Alkner U., Persson C. G. The 'nasal pool' device applies controlled concentrations of solutes on human nasal airway mucosa and samples its surface exudations/secretions. Clin Exp Allergy. 1990 May;20(3):253–259. doi: 10.1111/j.1365-2222.1990.tb02680.x. [DOI] [PubMed] [Google Scholar]
  65. Gundel R. H., Letts L. G., Gleich G. J. Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. J Clin Invest. 1991 Apr;87(4):1470–1473. doi: 10.1172/JCI115155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Haak-Frendscho M., Arai N., Arai K., Baeza M. L., Finn A., Kaplan A. P. Human recombinant granulocyte-macrophage colony-stimulating factor and interleukin 3 cause basophil histamine release. J Clin Invest. 1988 Jul;82(1):17–20. doi: 10.1172/JCI113567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Hallén H., Juto J. E. Nasal mucosa reaction. A model for mucosal reaction during challenge. Rhinology. 1992 Jun;30(2):129–133. [PubMed] [Google Scholar]
  68. Hamann K. J., Barker R. L., Ten R. M., Gleich G. J. The molecular biology of eosinophil granule proteins. Int Arch Allergy Appl Immunol. 1991;94(1-4):202–209. doi: 10.1159/000235362. [DOI] [PubMed] [Google Scholar]
  69. Hamid Q., Azzawi M., Ying S., Moqbel R., Wardlaw A. J., Corrigan C. J., Bradley B., Durham S. R., Collins J. V., Jeffery P. K. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest. 1991 May;87(5):1541–1546. doi: 10.1172/JCI115166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Hamid Q., Barkans J., Meng Q., Ying S., Abrams J. S., Kay A. B., Moqbel R. Human eosinophils synthesize and secrete interleukin-6, in vitro. Blood. 1992 Sep 15;80(6):1496–1501. [PubMed] [Google Scholar]
  71. Harlan J. M. Consequences of leukocyte-vessel wall interactions in inflammatory and immune reactions. Semin Thromb Hemost. 1987 Oct;13(4):434–444. doi: 10.1055/s-2007-1003520. [DOI] [PubMed] [Google Scholar]
  72. Henderson W. R., Chi E. Y., Klebanoff S. J. Eosinophil peroxidase-induced mast cell secretion. J Exp Med. 1980 Aug 1;152(2):265–279. doi: 10.1084/jem.152.2.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Henderson W. R., Jörg A., Klebanoff S. J. Eosinophil peroxidase-mediated inactivation of leukotrienes B4, C4, and D4. J Immunol. 1982 Jun;128(6):2609–2613. [PubMed] [Google Scholar]
  74. Hogg J. C. Neutrophil kinetics and lung injury. Physiol Rev. 1987 Oct;67(4):1249–1295. doi: 10.1152/physrev.1987.67.4.1249. [DOI] [PubMed] [Google Scholar]
  75. Holt P. G., Schon-Hegrad M. A., Oliver J. MHC class II antigen-bearing dendritic cells in pulmonary tissues of the rat. Regulation of antigen presentation activity by endogenous macrophage populations. J Exp Med. 1988 Feb 1;167(2):262–274. doi: 10.1084/jem.167.2.262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Hunter J. A., Finkbeiner W. E., Nadel J. A., Goetzl E. J., Holtzman M. J. Predominant generation of 15-lipoxygenase metabolites of arachidonic acid by epithelial cells from human trachea. Proc Natl Acad Sci U S A. 1985 Jul;82(14):4633–4637. doi: 10.1073/pnas.82.14.4633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Johansson S. G., Bennich H. Immunological studies of an atypical (myeloma) immunoglobulin. Immunology. 1967 Oct;13(4):381–394. [PMC free article] [PubMed] [Google Scholar]
  78. Joseph M., Tonnel A. B., Capron A., Voisin C. Enzyme release and superoxide anion production by human alveolar macrophages stimulated with immunoglobulin E. Clin Exp Immunol. 1980 May;40(2):416–422. [PMC free article] [PubMed] [Google Scholar]
  79. Joseph M., Tonnel A. B., Torpier G., Capron A., Arnoux B., Benveniste J. Involvement of immunoglobulin E in the secretory processes of alveolar macrophages from asthmatic patients. J Clin Invest. 1983 Feb;71(2):221–230. doi: 10.1172/JCI110762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Juliusson S., Bachert C., Klementsson H., Karlsson G., Pipkorn U. Macrophages on the nasal mucosal surface in provoked and naturally occurring allergic rhinitis. Acta Otolaryngol. 1991;111(5):946–953. doi: 10.3109/00016489109138435. [DOI] [PubMed] [Google Scholar]
  81. Juniper E. F., Guyatt G. H. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy. 1991 Jan;21(1):77–83. doi: 10.1111/j.1365-2222.1991.tb00807.x. [DOI] [PubMed] [Google Scholar]
  82. Kanzaki T., Yokota M., Mizuno N., Matsumoto Y., Hirabayashi Y. Novel lysosomal glycoaminoacid storage disease with angiokeratoma corporis diffusum. Lancet. 1989 Apr 22;1(8643):875–877. doi: 10.1016/s0140-6736(89)92867-5. [DOI] [PubMed] [Google Scholar]
  83. Kaplan A. P., Beaven M. A. In vivo studies of the pathogenesis of cold urticaria, cholinergic urticaria, and vibration-induced swelling. J Invest Dermatol. 1976 Sep;67(3):327–332. doi: 10.1111/1523-1747.ep12514352. [DOI] [PubMed] [Google Scholar]
  84. Kapsenberg M. L., Jansen H. M., Bos J. D., Wierenga E. A. Role of type 1 and type 2 T helper cells in allergic diseases. Curr Opin Immunol. 1992 Dec;4(6):788–793. doi: 10.1016/0952-7915(92)90063-k. [DOI] [PubMed] [Google Scholar]
  85. Khair O. A., Devalia J. L., Abdelaziz M. M., Sapsford R. J., Tarraf H., Davies R. J. Effect of Haemophilus influenzae endotoxin on the synthesis of IL-6, IL-8, TNF-alpha and expression of ICAM-1 in cultured human bronchial epithelial cells. Eur Respir J. 1994 Dec;7(12):2109–2116. doi: 10.1183/09031936.94.07122109. [DOI] [PubMed] [Google Scholar]
  86. Kita H., Ohnishi T., Okubo Y., Weiler D., Abrams J. S., Gleich G. J. Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils. J Exp Med. 1991 Sep 1;174(3):745–748. doi: 10.1084/jem.174.3.745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Klementsson H., Andersson M., Baumgarten C. R., Venge P., Pipkorn U. Changes in non-specific nasal reactivity and eosinophil influx and activation after allergen challenge. Clin Exp Allergy. 1990 Sep;20(5):539–547. doi: 10.1111/j.1365-2222.1990.tb03147.x. [DOI] [PubMed] [Google Scholar]
  88. Klementsson H., Svensson C., Andersson M., Venge P., Pipkorn U., Persson C. G. Eosinophils, secretory responsiveness and glucocorticoid-induced effects on the nasal mucosa during a weak pollen season. Clin Exp Allergy. 1991 Nov;21(6):705–710. doi: 10.1111/j.1365-2222.1991.tb03199.x. [DOI] [PubMed] [Google Scholar]
  89. Knauer K. A., Lichtenstein L. M., Adkinson N. F., Jr, Fish J. E. Platelet activation during antigen-induced airway reactions in asthmatic subjects. N Engl J Med. 1981 Jun 4;304(23):1404–1407. doi: 10.1056/NEJM198106043042307. [DOI] [PubMed] [Google Scholar]
  90. Kobayashi R. H., Kiechel F., 3rd, Kobayashi A. L., Mellion M. B. Topical nasal sprays: treatment of allergic rhinitis. Am Fam Physician. 1994 Jul;50(1):151-7, 161-2. [PubMed] [Google Scholar]
  91. Konno A., Yamakoshi T., Terada N., Fujita Y. Mode of action of a topical steroid on immediate phase reaction after antigen challenge and nonspecific nasal hyperreactivity in nasal allergy. Int Arch Allergy Immunol. 1994;103(1):79–87. doi: 10.1159/000236609. [DOI] [PubMed] [Google Scholar]
  92. Lai C. K., Jenkins J. R., Polosa R., Holgate S. T. Inhaled PAF fails to induce airway hyperresponsiveness to methacholine in normal human subjects. J Appl Physiol (1985) 1990 Mar;68(3):919–926. doi: 10.1152/jappl.1990.68.3.919. [DOI] [PubMed] [Google Scholar]
  93. Laitinen A., Partanen M., Hervonen A., Pelto-Huikko M., Laitinen L. A. VIP like immunoreactive nerves in human respiratory tract. Light and electron microscopic study. Histochemistry. 1985;82(4):313–319. doi: 10.1007/BF00494059. [DOI] [PubMed] [Google Scholar]
  94. Leggieri E., Tedeschi A., Lorini M., Bianco A., Miadonna A. Study of the effects of paf-acether on human nasal airways. Allergy. 1991 Aug;46(6):466–471. doi: 10.1111/j.1398-9995.1991.tb04226.x. [DOI] [PubMed] [Google Scholar]
  95. Lima M., Rocklin R. E. Histamine modulates in vitro IgG production by pokeweed mitogen-stimulated human mononuclear cells. Cell Immunol. 1981 Nov 1;64(2):324–336. doi: 10.1016/0008-8749(81)90484-6. [DOI] [PubMed] [Google Scholar]
  96. MacDermot J., Kelsey C. R., Waddell K. A., Richmond R., Knight R. K., Cole P. J., Dollery C. T., Landon D. N., Blair I. A. Synthesis of leukotriene B4, and prostanoids by human alveolar macrophages: analysis by gas chromatography/mass spectrometry. Prostaglandins. 1984 Feb;27(2):163–179. doi: 10.1016/0090-6980(84)90071-6. [DOI] [PubMed] [Google Scholar]
  97. Marasco W. A., Showell H. J., Becker E. L. Substance P binds to the formylpeptide chemotaxis receptor on the rabbit neutrophil. Biochem Biophys Res Commun. 1981 Apr 30;99(4):1065–1072. doi: 10.1016/0006-291x(81)90727-0. [DOI] [PubMed] [Google Scholar]
  98. Marin M. G., Davis B., Nadel J. A. Effect of histamine on electrical and ion transport properties of tracheal epithelium. J Appl Physiol Respir Environ Exerc Physiol. 1977 May;42(5):735–738. doi: 10.1152/jappl.1977.42.5.735. [DOI] [PubMed] [Google Scholar]
  99. May G. R., Crook P., Moore P. K., Page C. P. The role of nitric oxide as an endogenous regulator of platelet and neutrophil activation within the pulmonary circulation of the rabbit. Br J Pharmacol. 1991 Mar;102(3):759–763. doi: 10.1111/j.1476-5381.1991.tb12246.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. McCormick M. L., Roeder T. L., Railsback M. A., Britigan B. E. Eosinophil peroxidase-dependent hydroxyl radical generation by human eosinophils. J Biol Chem. 1994 Nov 11;269(45):27914–27919. [PubMed] [Google Scholar]
  101. Melmon K. L., Bourne H. R., Weinstein Y., Shearer G. M., Kram J., Bauminger S. Hemolytic plaque formation by leukocytes in vitro. Control by vasoactive hormones. J Clin Invest. 1974 Jan;53(1):13–21. doi: 10.1172/JCI107530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Motojima S., Frigas E., Loegering D. A., Gleich G. J. Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. Am Rev Respir Dis. 1989 Mar;139(3):801–805. doi: 10.1164/ajrccm/139.3.801. [DOI] [PubMed] [Google Scholar]
  103. Naclerio R. M., Proud D., Togias A. G., Adkinson N. F., Jr, Meyers D. A., Kagey-Sobotka A., Plaut M., Norman P. S., Lichtenstein L. M. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med. 1985 Jul 11;313(2):65–70. doi: 10.1056/NEJM198507113130201. [DOI] [PubMed] [Google Scholar]
  104. Noble S. L., Forbes R. C., Woodbridge H. B. Allergic rhinitis. Am Fam Physician. 1995 Mar;51(4):837–846. [PubMed] [Google Scholar]
  105. O'Neill G. P., Ford-Hutchinson A. W. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett. 1993 Sep 13;330(2):156–160. doi: 10.1016/0014-5793(93)80263-t. [DOI] [PubMed] [Google Scholar]
  106. Oelz O., Oelz R., Knapp H. R., Sweetman B. J., Oates J. A. Biosynthesis of prostaglandin D2. 1. Formation of prostaglandin D2 by human platelets. Prostaglandins. 1977 Feb;13(2):225–234. doi: 10.1016/0090-6980(77)90004-1. [DOI] [PubMed] [Google Scholar]
  107. Pelikan Z. Late and delayed responses of the nasal mucosa to allergen challenge. Ann Allergy. 1978 Jul;41(1):37–47. [PubMed] [Google Scholar]
  108. Pelikan Z. The changes in the nasal secretions of eosinophils during the immediate nasal response to allergen challenge. J Allergy Clin Immunol. 1983 Dec;72(6):657–662. doi: 10.1016/0091-6749(83)90625-5. [DOI] [PubMed] [Google Scholar]
  109. Peterson C. G., Skoog V., Venge P. Human eosinophil cationic proteins (ECP and EPX) and their suppressive effects on lymphocyte proliferation. Immunobiology. 1986 Mar;171(1-2):1–13. doi: 10.1016/S0171-2985(86)80013-4. [DOI] [PubMed] [Google Scholar]
  110. Pipkorn U., Proud D., Lichtenstein L. M., Kagey-Sobotka A., Norman P. S., Naclerio R. M. Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids. N Engl J Med. 1987 Jun 11;316(24):1506–1510. doi: 10.1056/NEJM198706113162403. [DOI] [PubMed] [Google Scholar]
  111. Rand T. H., Cruikshank W. W., Center D. M., Weller P. F. CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration. J Exp Med. 1991 Jun 1;173(6):1521–1528. doi: 10.1084/jem.173.6.1521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Richards I. M., Oostveen J. A., Griffin R. L., Bunting S. Pulmonary pharmacology of synthetic thromboxane A2. Adv Prostaglandin Thromboxane Leukot Res. 1987;17B:1067–1072. [PubMed] [Google Scholar]
  113. Rothenberg M. E., Petersen J., Stevens R. L., Silberstein D. S., McKenzie D. T., Austen K. F., Owen W. F., Jr IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity. J Immunol. 1989 Oct 1;143(7):2311–2316. [PubMed] [Google Scholar]
  114. Ruff M. R., Wahl S. M., Pert C. B. Substance P receptor-mediated chemotaxis of human monocytes. Peptides. 1985;6 (Suppl 2):107–111. doi: 10.1016/0196-9781(85)90142-1. [DOI] [PubMed] [Google Scholar]
  115. Samuelsson B., Dahlén S. E., Lindgren J. A., Rouzer C. A., Serhan C. N. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science. 1987 Sep 4;237(4819):1171–1176. doi: 10.1126/science.2820055. [DOI] [PubMed] [Google Scholar]
  116. Samuelsson B., Goldyne M., Granström E., Hamberg M., Hammarström S., Malmsten C. Prostaglandins and thromboxanes. Annu Rev Biochem. 1978;47:997–1029. doi: 10.1146/annurev.bi.47.070178.005025. [DOI] [PubMed] [Google Scholar]
  117. Schleimer R. P., Derse C. P., Friedman B., Gillis S., Plaut M., Lichtenstein L. M., MacGlashan D. W., Jr Regulation of human basophil mediator release by cytokines. I. Interaction with antiinflammatory steroids. J Immunol. 1989 Aug 15;143(4):1310–1317. [PubMed] [Google Scholar]
  118. Schleimer R. P., MacGlashan D. W., Jr, Peters S. P., Pinckard R. N., Adkinson N. F., Jr, Lichtenstein L. M. Characterization of inflammatory mediator release from purified human lung mast cells. Am Rev Respir Dis. 1986 Apr;133(4):614–617. doi: 10.1164/arrd.1986.133.4.614. [DOI] [PubMed] [Google Scholar]
  119. Schwartz L. B., Bradford T. R., Irani A. M., Deblois G., Craig S. S. The major enzymes of human mast cell secretory granules. Am Rev Respir Dis. 1987 May;135(5):1186–1189. doi: 10.1164/arrd.1987.135.5.1186. [DOI] [PubMed] [Google Scholar]
  120. Schwartz L. B., Lewis R. A., Austen K. F. Tryptase from human pulmonary mast cells. Purification and characterization. J Biol Chem. 1981 Nov 25;256(22):11939–11943. [PubMed] [Google Scholar]
  121. Sedgwick J. B., Calhoun W. J., Gleich G. J., Kita H., Abrams J. S., Schwartz L. B., Volovitz B., Ben-Yaakov M., Busse W. W. Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators. Am Rev Respir Dis. 1991 Dec;144(6):1274–1281. doi: 10.1164/ajrccm/144.6.1274. [DOI] [PubMed] [Google Scholar]
  122. Sedgwick J. B., Vrtis R. F., Gourley M. F., Busse W. W. Stimulus-dependent differences in superoxide anion generation by normal human eosinophils and neutrophils. J Allergy Clin Immunol. 1988 May;81(5 Pt 1):876–883. doi: 10.1016/0091-6749(88)90945-1. [DOI] [PubMed] [Google Scholar]
  123. Serhan C. N., Hamberg M., Samuelsson B. Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes. Proc Natl Acad Sci U S A. 1984 Sep;81(17):5335–5339. doi: 10.1073/pnas.81.17.5335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Siracusa A., Vecchiarelli A., Brugnami G., Marabini A., Felicioni D., Severini C. Changes in interleukin-1 and tumor necrosis factor production by peripheral blood monocytes after specific bronchoprovocation test in occupational asthma. Am Rev Respir Dis. 1992 Aug;146(2):408–412. doi: 10.1164/ajrccm/146.2.408. [DOI] [PubMed] [Google Scholar]
  125. Sonoda Y., Arai N., Ogawa M. Humoral regulation of eosinophilopoiesis in vitro: analysis of the targets of interleukin-3, granulocyte/macrophage colony-stimulating factor (GM-CSF), and interleukin-5. Leukemia. 1989 Jan;3(1):14–18. [PubMed] [Google Scholar]
  126. Spannhake E. W., Hyman A. L., Kadowitz P. J. Bronchoactive metabolites of arachidonic acid and their role in airway function. Prostaglandins. 1981 Dec;22(6):1013–1026. doi: 10.1016/0090-6980(81)90028-9. [DOI] [PubMed] [Google Scholar]
  127. Steffen M., Abboud M., Potter G. K., Yung Y. P., Moore M. A. Presence of tumour necrosis factor or a related factor in human basophil/mast cells. Immunology. 1989 Mar;66(3):445–450. [PMC free article] [PubMed] [Google Scholar]
  128. Stenson W. F., Parker C. W. Monohydroxyeicosatetraenoic acids (HETEs) induce degranulation of human neutrophils. J Immunol. 1980 May;124(5):2100–2104. [PubMed] [Google Scholar]
  129. Takatsu K., Tominaga A., Harada N., Mita S., Matsumoto M., Takahashi T., Kikuchi Y., Yamaguchi N. T cell-replacing factor (TRF)/interleukin 5 (IL-5): molecular and functional properties. Immunol Rev. 1988 Feb;102:107–135. doi: 10.1111/j.1600-065x.1988.tb00743.x. [DOI] [PubMed] [Google Scholar]
  130. Terada N., Konno A., Fukuda S., Yamashita T., Abe T., Shimada H., Yoshimura K., Shirotori K., Ishikawa K., Togawa K. Interleukin-5 upregulates intercellular adhesion molecule-1 gene expression in the nasal mucosa in nasal allergy but not in nonallergic rhinitis. Int Arch Allergy Immunol. 1995 Feb;106(2):139–145. doi: 10.1159/000236834. [DOI] [PubMed] [Google Scholar]
  131. Terada N., Konno A., Tada H., Shirotori K., Ishikawa K., Togawa K. The effect of recombinant human interleukin-5 on eosinophil accumulation and degranulation in human nasal mucosa. J Allergy Clin Immunol. 1992 Aug;90(2):160–168. doi: 10.1016/0091-6749(92)90067-c. [DOI] [PubMed] [Google Scholar]
  132. Touqui L., Herpin-Richard N., Gene R. M., Jullian E., Aljabi D., Hamberger C., Vargaftig B. B., Dessange J. F. Excretion of platelet activating factor-acetylhydrolase and phospholipase A2 into nasal fluids after allergenic challenge: possible role in the regulation of platelet activating factor release. J Allergy Clin Immunol. 1994 Jul;94(1):109–119. doi: 10.1016/0091-6749(94)90077-9. [DOI] [PubMed] [Google Scholar]
  133. Tung R., Kagey-Sobotka A., Plaut M., Lichtenstein L. M. H2 antihistamines augment antigen-induced histamine release from human basophils in vitro. J Immunol. 1982 Nov;129(5):2113–2115. [PubMed] [Google Scholar]
  134. Turk J., Maas R. L., Brash A. R., Roberts L. J., 2nd, Oates J. A. Arachidonic acid 15-lipoxygenase products from human eosinophils. J Biol Chem. 1982 Jun 25;257(12):7068–7076. [PubMed] [Google Scholar]
  135. Vane J. R., Mitchell J. A., Appleton I., Tomlinson A., Bishop-Bailey D., Croxtall J., Willoughby D. A. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2046–2050. doi: 10.1073/pnas.91.6.2046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Vargaftig B. B., Lefort J., Chignard M., Benveniste J. Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives. Eur J Pharmacol. 1980 Jul 25;65(2-3):185–192. doi: 10.1016/0014-2999(80)90391-x. [DOI] [PubMed] [Google Scholar]
  137. Varney V. A., Jacobson M. R., Sudderick R. M., Robinson D. S., Irani A. M., Schwartz L. B., Mackay I. S., Kay A. B., Durham S. R. Immunohistology of the nasal mucosa following allergen-induced rhinitis. Identification of activated T lymphocytes, eosinophils, and neutrophils. Am Rev Respir Dis. 1992 Jul;146(1):170–176. doi: 10.1164/ajrccm/146.1.170. [DOI] [PubMed] [Google Scholar]
  138. Viegas M., Gomez E., Brooks J., Davies R. J. Changes in nasal mast cell numbers in and out of the pollen season. Int Arch Allergy Appl Immunol. 1987;82(3-4):275–276. doi: 10.1159/000234205. [DOI] [PubMed] [Google Scholar]
  139. Walsh G. M., Hartnell A., Wardlaw A. J., Kurihara K., Sanderson C. J., Kay A. B. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner. Immunology. 1990 Oct;71(2):258–265. [PMC free article] [PubMed] [Google Scholar]
  140. Walters E. H., Parrish R. W., Bevan C., Smith A. P. Induction of bronchial hypersensitivity: evidence for a role for prostaglandins. Thorax. 1981 Aug;36(8):571–574. doi: 10.1136/thx.36.8.571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Wang J. M., Rambaldi A., Biondi A., Chen Z. G., Sanderson C. J., Mantovani A. Recombinant human interleukin 5 is a selective eosinophil chemoattractant. Eur J Immunol. 1989 Apr;19(4):701–705. doi: 10.1002/eji.1830190420. [DOI] [PubMed] [Google Scholar]
  142. Warner J. A., Pienkowski M. M., Plaut M., Norman P. S., Lichtenstein L. M. Identification of histamine releasing factor(s) in the late phase of cutaneous IgE-mediated reactions. J Immunol. 1986 Apr 1;136(7):2583–2587. [PubMed] [Google Scholar]
  143. Warringa R. A., Mengelers H. J., Kuijper P. H., Raaijmakers J. A., Bruijnzeel P. L., Koenderman L. In vivo priming of platelet-activating factor-induced eosinophil chemotaxis in allergic asthmatic individuals. Blood. 1992 Apr 1;79(7):1836–1841. [PubMed] [Google Scholar]
  144. Wasserman S. I., Goetzl E. J., Austen K. F. Inactivation of slow reacting substance of anaphylaxis by human eosinophil arylsulfatase. J Immunol. 1975 Feb;114(2 Pt 1):645–649. [PubMed] [Google Scholar]
  145. Wasserman S. I. Mast cells and airway inflammation in asthma. Am J Respir Crit Care Med. 1994 Nov;150(5 Pt 2):S39–S41. doi: 10.1164/ajrccm/150.5_Pt_2.S39. [DOI] [PubMed] [Google Scholar]
  146. Wenzel S. E., Westcott J. Y., Smith H. R., Larsen G. L. Spectrum of prostanoid release after bronchoalveolar allergen challenge in atopic asthmatics and in control groups. An alteration in the ratio of bronchoconstrictive to bronchoprotective mediators. Am Rev Respir Dis. 1989 Feb;139(2):450–457. doi: 10.1164/ajrccm/139.2.450. [DOI] [PubMed] [Google Scholar]
  147. Wihl J. A., Malm L. Rhinomanometry and nasal peak expiratory and inspiratory flow rate. Ann Allergy. 1988 Jul;61(1):50–55. [PubMed] [Google Scholar]
  148. Wodnar-Filipowicz A., Heusser C. H., Moroni C. Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation. Nature. 1989 May 11;339(6220):150–152. doi: 10.1038/339150a0. [DOI] [PubMed] [Google Scholar]
  149. Yasaka T., Boxer L. A., Baehner R. L. Monocyte aggregation and superoxide anion release in response to formyl-methionyl-leucyl-phenylalanine (FMLP) and platelet-activating factor (PAF). J Immunol. 1982 May;128(5):1939–1944. [PubMed] [Google Scholar]
  150. Zeiger R. S., Yurdin D. L., Colten H. R. Histamine metabolism. II. Cellular and subcellular localization of the catabolic enzymes, histaminase and histamine methyl transferase, in human leukocytes. J Allergy Clin Immunol. 1976 Jul;58(1 Pt 2):172–179. doi: 10.1016/0091-6749(76)90152-4. [DOI] [PubMed] [Google Scholar]
  151. de Graaf-in't Veld C., Garrelds I. M., Jansen A. P., Van Toorenenbergen A. W., Mulder P. G., Meeuwis J., Gerth van Wijk R. Effect of intranasal fluticasone proprionate on the immediate and late allergic reaction and nasal hyperreactivity in patients with a house dust mite allergy. Clin Exp Allergy. 1995 Oct;25(10):966–973. doi: 10.1111/j.1365-2222.1995.tb00399.x. [DOI] [PubMed] [Google Scholar]
  152. de Waal Malefyt R., Abrams J., Bennett B., Figdor C. G., de Vries J. E. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991 Nov 1;174(5):1209–1220. doi: 10.1084/jem.174.5.1209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  153. van Wijk R. G., Dieges P. H., van Toorenenbergen A. W. Seasonal variability in nasal sensitivity to house dust mite extract. Rhinology. 1987 Mar;25(1):41–48. [PubMed] [Google Scholar]
  154. van Wijk R. G., Mulder P. G., Dieges P. H. Nasal provocation with histamine in allergic rhinitis patients: clinical significance and reproducibility. Clin Exp Allergy. 1989 May;19(3):293–298. doi: 10.1111/j.1365-2222.1989.tb02386.x. [DOI] [PubMed] [Google Scholar]
  155. van Wijk R. G., Zijlstra F. J., van Toorenenbergen A. W., Vermeulen A., Dieges P. H. Isolated early response after nasal allergen challenge is sufficient to induce nasal hyperreactivity. Ann Allergy. 1992 Jul;69(1):43–47. [PubMed] [Google Scholar]
  156. van Wijk R. G., van Toorenenbergen A. W., Zijlstra F. J., Jansen A. P., Dieges P. H. Nasal hyperreactivity and its effect on early and late sequelae of nasal challenge with house-dust mite extract. Allergy Proc. 1993 Jul-Aug;14(4):273–281. doi: 10.2500/108854193778812026. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES